Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — April 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    Plimsoller
    wrote on sidst redigeret af
    #495

    Thank you E L. A quick question. Do you know if a drug has ever been rejected after having been issued a priority review?

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #496

      not on top of my head; i would have to search, but priority review is not a guarantee for approval (which i think is your real question?)

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #497

        would indeed be interesting to see the % approvals for normal vs priority applications

        1 Reply Last reply
        0
        • S Offline
          S Offline
          Sukkeralf
          wrote on sidst redigeret af
          #498

          ASCO title release 28/4 and full abstract release 19/5

          1 Reply Last reply
          0
          • StockBullS Offline
            StockBullS Offline
            StockBull
            wrote on sidst redigeret af
            #499

            Ja bussen kørte 12 Marts da vi fik macd købssignal https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/91849_macd_buy_signal.png

            1 Reply Last reply
            0
            • S Offline
              S Offline
              Sukkeralf
              wrote on sidst redigeret af
              #500

              Plim: Designation of a drug as “Priority” does not alter the scientific/medical standard for approval or the quality of evidence necessary.

              1 Reply Last reply
              0
              • S Offline
                S Offline
                Sukkeralf
                wrote on sidst redigeret af
                #501

                https://www.fda.gov/patients/fast-track-breakthrough-therapy-accelerated-approval-priority-review/priority-review

                1 Reply Last reply
                0
                • StockBullS Offline
                  StockBullS Offline
                  StockBull
                  wrote on sidst redigeret af
                  #502

                  Hvordan definere du et stabilt brud af 2180 TheNote, stor volumen formoder jeg. Enig i det ser godt ud

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    Plimsoller
                    wrote on sidst redigeret af
                    #503

                    E L and Sukker. No - my question was just about the historical relationship between the PR and the approval, as there must be some criteria met to obtain a PR. I realise that it potentially still can fail and that it, with good reason, still has to live up to the normal standards. Thank you both for replying. E L, no need to search. I trust your memory 🙂

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      Plimsoller
                      wrote on sidst redigeret af
                      #504

                      Og tak for link Sukker 🙂

                      1 Reply Last reply
                      0
                      • StockBullS Offline
                        StockBullS Offline
                        StockBull
                        wrote on sidst redigeret af
                        #505

                        5års grafen er også ved at indikere køb på RSI og MACD

                        1 Reply Last reply
                        0
                        • SolsenS Offline
                          SolsenS Offline
                          Solsen
                          wrote on sidst redigeret af
                          #506

                          Passer jo fint med opkøb i forventning til ASCO

                          1 Reply Last reply
                          0
                          • StockBullS Offline
                            StockBullS Offline
                            StockBull
                            wrote on sidst redigeret af
                            #507

                            Ja det er lige efter bogen som tidligere år hat April - Maj som regel være gode for Genmab

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #508

                              the FDA always very proudly lists all the drugs they approved in a year, but it is somehow much harder to find a list of the drugs that were rejected...

                              1 Reply Last reply
                              0
                              • R Offline
                                R Offline
                                Rondo
                                wrote on sidst redigeret af
                                #509

                                ja ...når nogen nævner MacD fremad rettet vil jeg være opmærksom .... 😉

                                1 Reply Last reply
                                0
                                • BulderB Offline
                                  BulderB Offline
                                  Bulder
                                  wrote on sidst redigeret af
                                  #510

                                  Når genmab indsender ansøgning på basis af et fase 2 studie, sker det ikke uden forudgående konsultationer hos FDA. Og når FDA desuden tildeler PR, skal en afvisning være begrundet en alvorlig brist i datamaterialet. Det tror jeg ikke på, men det er selvfølgelig en mulighed.

                                  1 Reply Last reply
                                  0
                                  • StockBullS Offline
                                    StockBullS Offline
                                    StockBull
                                    wrote on sidst redigeret af
                                    #511

                                    Man skal altid være opmærksom og ikke basere sine køb på en enkelt indikator. MACD er kun en af mange indikatore jeg kigger på.

                                    1 Reply Last reply
                                    0
                                    • StockBullS Offline
                                      StockBullS Offline
                                      StockBull
                                      wrote on sidst redigeret af
                                      #512

                                      eller salg

                                      1 Reply Last reply
                                      0
                                      • R Offline
                                        R Offline
                                        Rondo
                                        wrote on sidst redigeret af
                                        #513

                                        jeg har en del basis Genmab som ligger fast pga af jeg vurdere Casen er go, også har jeg en del jeg swinger med, efter tendenser og indikationer.... og ja det undgåes ikke at få en over nallerne ind i mellem , men sommetider bliver det også vældig godt.... jeg ved skattevæsnet over vejer at sende blomster og takke kort til mig, eller det burde de gør ... 🙂 🙂 🙂 🙂

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #514

                                          Jan yesterday spoke about the hope 'to move at least 1 more proprietary product into late stage clinical development' - Is it fair to assume he means GEN1046/DuoBody-PD-L1x4-1BB
                                          with that?

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger